[DISCREPA study: treatment of advanced Parkinson’s disease and use of second-line treatments in Catalonia].

[DISCREPA study: treatment of advanced Parkinson’s disease and use of second-line treatments in Catalonia].
Related Articles[DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia]. Rev Neurol. 2021 Jan 01;72(1):1-8 Authors: Ávila A, Pastor P, Planellas L, Gil-Villar MP, Hernández-Vara J, Fernández-Dorado A Abstract INTRODUCTION: The treatment of Parkinson's disease (PD) is complex, and the establishment of second-line therapies in advanced PD remains controversial. AIM: To analyze the assistance of ... read more
Source: PubMedPublished on 2020-12-31